Donor influence on outcome in patients undergoing liver transplant for primary biliary cirrhosis

Experimental and Clinical Transplantation

Volumn 8, Issue 2, 2010, Pages

  Jacob, Dietmar A ^a   Haase, Elena ^a   Klein, Fritz ^a   Pratschke, Johann ^a   Neumann, Ulf P ^a   Neuhaus, Peter ^a   Bahra, Marcus ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Intensive care unit; Liver disease; Surgery

Indexed keywords

ADRENALIN; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; ERYTHROCYTE TRANSFUSION; FATTY LIVER; FEMALE; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDROPS; HYPOTENSION; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER FIBROSIS; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIMARY BILIARY CIRRHOSIS; RECURRENCE RISK; RISK FACTOR; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 77954105433     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tinmouth J, Tomlinson G, Heathcote EJ, Lilly L. Benefit of transplantation in primary biliary cirrhosis between 1985-1997. Transplantation. 2002;73:224-227.
2. Neuberger J, Portmann B, Macdougall BR, Calne RY, Williams R. Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med. 1982;306:1-4.
3. Knoop M, Bechstein WO, Schrem H, Lobeck H, Hopf U, Neuhaus P. Clinical significance of recurrent primary biliary cirrhosis after liver transplantation. Transpl Int. 1996;9(suppl 1):S115-S119.
4. Sylvestre PB, Batts KP, Burgart LJ, Poterucha JJ, Wiesner RH. Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history. Liver Transpl. 2003;9:1086-1093.
5. Levitsky J, Hart J, Cohen SM, Te HS. The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation. Liver Transpl. 2003;9:733-736.
6. Khettry U, Anand N, Faul PN, et al. Liver transplantation for primary biliary cirrhosis: a long-term pathologic study. Liver Transpl. 2003;9:87-96.
7. Salguero O, Moreno JM, Seijas MC, et al. Recurrence of primary biliary cirrhosis after liver transplantation. Transplant Proc. 2003;35:721-722.
8. Kaplan MM. Primary biliary cirrhosis. N Engl J Med. 1996;335:1570-1580.
9. Neuberger J. Recurrent primary biliary cirrhosis. Liver Transpl. 2003;9:539-546.
10. Liermann Garcia RF, Evangelista Garcia C, McMaster P, Neuberger J. Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology. 2001;33:22-27.
11. Wong PY, Portmann B, O'Grady JG, et al. Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression. J Hepatol. 1993;17:284-287.
12. Garcia CE, Garcia RF, Gunson B, et al. Analysis of marginal donor parameters in liver transplantation for primary biliary cirrhosis. Exp Clin Transplant. 2004;2:183-188.
13. Guy JE, Qian P, Lowell JA, Peters MG. Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant. Liver Transpl. 2005;11:1252-1257.
14. Neuhaus P, Blumhardt G, Bechstein WO, Steffen R, Platz KP, Keck H. Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg. 1994;219:426-434.
15. Neuhaus P, Bechstein WO, Blumhardt G, et al. Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody. Transplantation. 1993;55:1320-1327.
16. Neuhaus P, Blumhardt G. Extended bile duct resection--a new oncological approach to the treatment of central bile duct carcinomas? Description of method and early results. Langenbecks Arch Chir. 1994;379:123-128.
17. Hubscher SG, Elias E, Buckels JA, Mayer AD, McMaster P, Neuberger JM. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol. 1993;18:173-184.
18. Maheshwari A, Yoo HY, Thuluvath PJ. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC. Am J Gastroenterol. 2004;99:538-542.
19. Jacob DA, Neumann UP, Bahra M, et al. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients. Clin Transplant. 2006;20:211-220.
20. Jacob DA, Neumann UP, Bahra M, Langrehr JM, Neuhaus P. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival. Transplant Proc. 2005;37:1691-1692.
21. Rull R, Vidal O, Momblan D, et al. Evaluation of potential liver donors: limits imposed by donor variables in liver transplantation. Liver Transpl. 2003;9:389-393.
22. Mor E, Klintmalm GB, Gonwa TA, et al. The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation. 1992;53:383-386.
23. Neuberger J, Gunson B, Hubscher S, Nightingale P. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl. 2004;10:488-491.
24. Bahra M, Jacob D, Neumann UP, et al. Influence of donor histology on outcome in patients undergoing transplantation for hepatitis C. Transplantation. 2007;84:144-148.
25. Hytiroglou P, Gutierrez JA, Freni M, et al. Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study. Hepatol Res. 2009;39(6):577-584